Abstract
Mammaglobin-A is exclusively expressed by breast cancer cells. Thus, mammaglobin-A-specific T cell immune responses may be useful for the design of new breast cancer-specific immunotherapies. We show herein that CD8+ T cells generated against recombinant mammaglobin-A-pulsed dendritic cells display a marked cytotoxic activity against mammaglobin-A-positive breast cancer cell lines. This study indicates the immunotherapeutic potential of this novel antigen for the treatment of breast cancer.
Similar content being viewed by others
References
Watson MA, Fleming TP: Isolation of differentially expressed sequence tags from human breast cancer. Cancer Res 54: 4598–4602, 1994
Watson MA, Fleming TP: Mammaglobin, a mammary specific member of the uteroglobin gene family, is overexpressed in human breast cancer. Cancer Res 56: 860–865, 1996
Watson MA, Darrow C, Zimonjic DB, Popescu NC, Fleming TP: Structure and transcriptional regulation of the human mammaglobin gene, a breast cancer associated member of the uteroglobin gene family localized to chromosome 11q13. Oncogene 16: 817–824, 1998
Fleming TP, Watson MA: Mammaglobin, a breast-specific gene, and its utility as a marker for breast cancer. Ann NY Acad Sci 923: 78–89, 2000
Marchetti A, Buttitta F, Bertacca G, Zavaglia K, Bevilacqua G, Angelucci D, Viacava P, Naccarato A, Bonadio A, Barassi F, Felicioni L, Salvatore S, Mucilli F: mRNA markers of breast cancer nodal metastases: comparison between mammaglobin and carcinoembryonic antigen in 248 patients. J Pathol 195: 186–190, 2001
Grunewald K, Haun M, Urbanek M, Fiegel M, Muller-Holzner E, Gunsilius E, Dunser M, Marth C, Castle G: Mammaglobin gene expression: a superior marker of breast cancer cells in peripheral blood in comparison to epidermal growth factor receptor and cytokeratin-19. Lab Invest 80: 1071–1077, 2000
Paik S, Burkhard E, Lippman ME: Clinical significance of erb/b2 protein overexpression. Cancer Treat Res 61: 181–191, 1992
Keyomarsi K, Pardee AB: Redundant cyclin overexpression and gene amplification in breast cancer cells. P Natl Acad Sci USA 90: 1112–1116, 1993
Watson MA, Dintzis S, Darrow CM, Voss LE, DiPersio J, Jensen R, Fleming TP: Mammaglobin expression in primary, metastatic and occult breast cancer. Cancer Res 59: 3028–3031, 1999
Zhou JL, Tedder TF: CD14+ blood monocytes can differentiate into functionally mature CD83+ dendritic cells. P Natl Acad Sci USA 93: 2588–2592, 1996
Jaramillo A, Majunder K, Manna PP, Fleming TP, Doherty G, Dipersio JF, Mohanakumar T: Identification of HLA-A3-restricted CD8+ T cell epitopes derived from mammaglobin-A, a tumor-associated antigen of human breast cancer. Int J Cancer 102: 499–506, 2002
Berke G: The binding and lysis of target cells by cytotoxic lymphocytes: molecular and cellular aspects. Annu Rev Immunol 12: 735–773, 1994
Bevan MJ: Antigen presentation to cytotoxic T lymphocytes in vivo. J Exp Med 182: 639–641, 1995
Brossart P, Stuhler G, Flad T, Stevanovic S, Rammensee H-G, Kanz L, Brugger W: Her-2/neu derived peptides are tumor associated antigens expressed by human renal cell and colon carcinomalines and are recognized by in vitro induced specific cytotoxic T lymphocytes. Cancer Res 58: 732–736, 1998
Kawashima I, Tsai V, Southwood S, Takesako K, Sette A, Celis E: Identification of HLA-A3 restricted cytotoxic T lymphocyte epitopes from carcinoembryonic antigen and Her-2/neu by primary in vitro immunization with peptide pulsed dendritic cells. Cancer Res 59: 431–435, 1999
Cella M, Sallusto F, Lanzavecchia L: Origin, maturation and antigen presenting function of dendritic cells. Curr Opin Immunol 9: 10–16, 1997
Zitovogel L, Mayordoma JI, Storkus WJ, Lotze MT, Falo LD: Therapy of murine tumors with tumor peptide pulsed dendritic cells: dependence on T cells, B7 costimulation, and T helper cell associated cytokines. J Exp Med 183: 87–97, 1996
Pagalia P, Chiodoni C, Rodolfo M, Colombo MP: Murine dendritic cells loaded in vitro with soluble protein prime cytotoxic T lymphocytes against tumor antigen in vivo. J ExpMed 183: 317–322, 1996
Ashley DM, Faiola B, Nair S, Hale LP, Bigner DD, Gilboa E: Bone marrow generated dendritic cells pulsed with tumor extract or tumor RNA induce anti-tumor immunity against central nervous system tumors. J Exp Med 186: 1177–1182, 1997
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Manna, P.P., Jaramillo, A., Majumder, K. et al. Generation of CD8+ Cytotoxic T Lymphocytes Against Breast Cancer Cells by Stimulation with Mammaglobin-A-Pulsed Dendritic Cells. Breast Cancer Res Treat 79, 133–136 (2003). https://doi.org/10.1023/A:1023323509888
Issue Date:
DOI: https://doi.org/10.1023/A:1023323509888